ArticleScientific reports2025
Association of waist circumference with all cause mortality in Parkinson's disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Despite many previous studies on the association between metabolic syndrome and Parkinson disease (PD), only few studies have investigated the association between waist circumference (WC) and PD. The aim of this study is to investigate the association between WC and all-cause mortality in patients with PD. Among the whole nationwide population data from Korea National Health Insurance Service, newly diagnosed PD (ICD-10 code G20 and rare intractable disease registration code V124), between 2008 and 2017, were selected. All-cause mortality was the primary outcome. Anthropometric data, including WC and body mass index (BMI) were obtained from health screening data. The Cox proportional hazards model was used to assess mortality risk according to WC. Among the 22,118 patients with PD, 9,179 (41.50%) died during the 10-year follow-up period. WCs < 70 cm among males and < 65 cm among females were significantly associated with increased mortality in patients with PD (HR = 1.19, 95% CI, 1.05-1.34). After adjusting for BMI, WC of ≥ 90 cm in males or ≥ 85 cm in females, which are the criteria for central obesity, increased mortality risk significantly (M 90-100, F 85-95: HR = 1.13, 95% CI, 1.05-1.22; M ≥ 100, F ≥ 95: HR = 1.50, 95% CI, 1.33-1.68). The association between WC and PD mortality revealed a J-shaped pattern among males and a U-shaped pattern among females. Central obesity is a significant risk factor for mortality in patients with PD after adjusting for BMI. Our results suggest that management of WC is crucial for PD patients and that BMI should be considered in the WC management plan for mortality in PD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.